SCHEMBL6795231

SCHEMBL6795231

Nc1ccc(SCCc2ccccn2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.66
NPC1 O15118 1/20 0.66
RAB9A P51151 1/20 0.66
HRH1 P35367 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.51
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
PRMT1 Q99873 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HRH3 Q9Y5N1 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GAA P10253 1/20 0.42
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320855 0.86 ALDH1A1 (0.69) ALDH1A1NPC1RAB9AHRH1HRH3
Hydrochloric Acid SCHEMBL16346388 0.84 ALDH1A1 (0.67) ALDH1A1NPC1RAB9AHRH1MEN1
SCHEMBL16346747 0.83 ALDH1A1 (0.66) ALDH1A1NPC1RAB9AHRH1MEN1
SCHEMBL15702601 0.83 ALDH1A1 (0.66) ALDH1A1NPC1RAB9AHRH1MEN1
SCHEMBL10143932 0.83 ALDH1A1 (0.70) ALDH1A1NPC1RAB9AHRH1MEN1
SCHEMBL3388873 0.83 L3MBTL1 (0.54) ALDH1A1NPC1RAB9AHRH1L3MBTL1
Hydrochloric Acid SCHEMBL16346548 0.82 ALDH1A1 (0.68) ALDH1A1NPC1RAB9AHRH1MEN1
SCHEMBL4615168 0.80 ALDH1A1 (0.61) ALDH1A1NPC1RAB9AHRH1MEN1
SCHEMBL16376234 0.80 RAB9A (0.65) ALDH1A1NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL16346496 0.78 RAB9A (0.63) ALDH1A1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed
CN-1478077-A Benzamide compounds as APO B secretion inhibitors ����ҩƷ��ҵ��ʽ���� 2004-02-25 CN disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 ALDH1A1 1427/4885NPC1 64/4885RAB9A 3707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.